Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd is quoting at Rs 2510.4, up 1.92% on the day as on 12:49 IST on the NSE. The stock is up 32.94% in last one year as compared to a 4.13% jump in NIFTY and a 16.41% jump in the Nifty Pharma index.
HDFC Securities analyst flags key support levels for Nifty; 2 stocks to buy
Gland Pharma has given a breakout from a bullish 'Inverted head and shoulder' pattern, and Viyash Scientific from bullish 'Cup and handle pattern', says Vinay Rajani of HDFC Securities.
Honasa Consumer, 6 other stocks hit 52-week highs, rally up to 35% in a month
Despite weakness in the broader market, seven BSE 500 stocks including Honasa Consumer, Aegis Logistics and Gland Pharma scaled fresh 52-week highs, gaining up to 35% over the past month amid strong investor buying.
Five Stocks To Buy: Adani Energy, Adani Green, Gland Pharma And More | June 08, 2026
Top picks include power transmission major Adani Energy Solutions, renewable energy giant Adani Green Energy, pharma player Gland Pharma, automotive major Ashok Leyland, and carbon materials manufacturer Himadri Speciality Chemical.
Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?
The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Gland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving profitability. Future growth is anticipated from capacity expansions and new product lines. The company's contract development and manufacturing business is also expanding. Investors are watching Gland Pharma's growth prospects.
Gland Pharma,6 stocks hit 52-week highs, rally up to 20% in a month
Sensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15% - Equitymaster
Sensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15%Equitymaster
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescue - The Times of India
Stock Market Highlights: BSE Sensex ends in green after 1,000 point intra-day crash; Nifty50 closes at 23,650 as IT stocks rally comes to rescueThe Times of IndiaWhy is market falling today? Sensex falls 600 points, Nifty below 23,500; 5 key factors behind bloodbathThe Economic TimesSensex Today Ends Marginally Higher | Nifty Above 23,600 | Gland Pharma Up 15%Equitymaster
Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainers
Indian stocks marginally gained on May 18, driven by strong tech buying and pharma support, with Nifty 50 up 0.03% at 23,649 and BSE Sensex at 75,263. However, the broader market faced pressure as Nifty Midcap 100 and Nifty Smallcap 100 fell.
Why Gland Pharma Share Price is Rising - Equitymaster
Why Gland Pharma Share Price is RisingEquitymaster
Gland Pharma shares gain most in nearly three years after Q4 results, brokerage upgrade
Of the 18 analysts who have coverage on Gland Pharma, 13 have a "buy" rating, two have a "hold" rating and three havve a "sell" rating.